Etoposide protects mice from radiation-induced bone marrow death

Area of Science:

• Radiation oncology
• Cancer biology
• Pharmacology

Background:

• Etoposide inhibits topoisomerase II, an enzyme crucial for DNA replication and repair.
• Etoposide is recognized for its radiosensitizing properties, enhancing radiation therapy's effectiveness.
• Radiation-induced bone marrow suppression is a significant dose-limiting toxicity in radiation therapy.

Purpose of the Study:

• To investigate the protective effects of etoposide pretreatment against radiation-induced bone marrow death.
• To determine if etoposide can mitigate the lethal consequences of whole-body irradiation.
• To assess the impact of etoposide on hematopoietic stem cell survival post-irradiation.

Main Methods:

• Mice were pretreated with etoposide one day prior to whole-body irradiation.
• Lethal dose 50/30 (LD50/30) was determined for mice receiving radiation alone versus etoposide pretreatment followed by irradiation.
• The number of endogenous spleen colony-forming units (CFUs) was quantified to assess hematopoietic recovery.

Main Results:

• Etoposide pretreatment significantly increased the LD50/30 from 8.26 Gy to 10.35 Gy, indicating enhanced survival.
• A notable increase in surviving endogenous colony-forming units was observed in mice pretreated with etoposide.
• These findings suggest a radioprotective effect of etoposide on bone marrow.

Conclusions:

• Etoposide exhibits a protective effect against radiation-induced bone marrow lethality.
• Pretreatment with etoposide can improve survival outcomes following high-dose irradiation.
• Etoposide may play a role in mitigating radiation toxicity by preserving hematopoietic stem cell function.